Skip to content

Early Prosthetics in Children With Upper Limb Deficiency

Adaptative Motor Behavior of Children With Unilateral Upper Limb Deficiency After Early Prosthetics.

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04851600
Acronym
EARLIMB
Enrollment
30
Registered
2021-04-20
Start date
2021-05-31
Completion date
2026-05-31
Last updated
2021-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Limb Deficiencies

Keywords

Unilateral congenital upper extremity deficiency, Early development, Motor skills, Rehabilitation of amputees, Upper extremity deficiency, Upper limb prosthesis, Adaptative behavior

Brief summary

For children with congenital upper limb deficiency, introduction of the prosthesis is guided by clinical experience rather than by Evidence Based Medicine. This study will assess early development in children with upper limb deficiency according to age at the introduction of the prosthesis. This study will give new keys in these specific prosthesis cares.

Interventions

DEVICEprosthesis

Casting and delivery of a cosmetic upper limb prosthesis at 3-4 months old of age.

Sponsors

University Hospital, Lille
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Months to 3 Months
Healthy volunteers
No

Inclusion criteria

* Male or female child * Aged from 1 month to 3 months and a half * Placement of a prosthesis in a patient with isolated upper limb deficiency, type of congenital transverse unilateral amputation of the forearm segment * Socially insured patient, * Patient willing to comply with all study procedures and study duration * Written informed consent from patient's legal guardians

Exclusion criteria

* Children with one or more high risk factors for neurodevelopmental disorders: * Very prematurity (\<32 weeks of amenorrhea \[SA\]) * Premature infants \<37 WA with intrauterine growth retardation (IUGR) or low weight for gestational age (PAG) \<3rd percentile or \<- 2 SD for GA and sex according to national reference curves) * A presumed hypoxo-ischemic encephalopathy with an indication of therapeutic hypothermia * A perinatal arterial cerebrovascular accident (AVC) (diagnosed between the 20th week of fetal life and the 28th day of life including in premature newborns). * Cerebral growth anomalies: microcephaly with cranial perimeter \<- 2 SD at birth verified secondarily or macrocephaly\> + 3 SD for the term (persisting after a second measurement). * A family history of severe first-degree neurodevelopmental disorder (brother or sister or parent) * Symptomatic congenital cytomegalovirus infections and other infectious fetopathies: toxoplasmosis, Zika, rubella, etc. * Bacterial and viral herpetic meningoencephalitis * Complex congenital heart disease operated on: transposition of the large vessels; left ventricular hypoplastic syndrome. * Perinatal exposure to a major toxicant: certain antiepileptics (sodium valproate); severe exposure to alcohol and / or with signs of fetal disease. * Major, prolonged and repeated surgery (cardiac, cerebral, abdominal, thoracic). * Exclusion of all deficiency forming part of a polymalformative, vascular syndrome (Poland syndrome), genetic cause ... * Exclusion of all other forms of agenesis (bilateral, longitudinal, persistence of hand remains), * Refusal of consent from one or both parents

Design outcomes

Primary

MeasureTime frame
Vineland Adaptive Behavior Scales version II Motor skills Domain score Motor skills Domain scoreat 24 months old

Secondary

MeasureTime frame
Assisting Hand Assessmentat 3 years old
Communication Domain Scoreat 9 months old , at 24 months old
Daily living skills Domain Score at 9 and 24 months oldat 9 months old , at 24 months old, at 3 years old
Socialization Domain scoreat 9 months old , at 24 months old, at 3 years old
Motor skills Domain scoreat 9 months old

Countries

France

Contacts

Primary ContactAlice TAQUET, MD
alice.taquet@marcsautelet.com03 28 80 07 70

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026